Sultan Shahnaz, Shung Dennis L, Kolb Jennifer M, Foroutan Farid, Hassan Cesare, Kahi Charles J, Liang Peter S, Levin Theodore R, Siddique Shazia Mehmood, Lebwohl Benjamin
Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota; Minneapolis Veterans Affairs Healthcare System, Minneapolis, Minnesota.
Department of Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut.
Gastroenterology. 2025 Apr;168(4):691-700. doi: 10.1053/j.gastro.2025.01.002.
BACKGROUND & AIMS: This American Gastroenterological Association (AGA) guideline is intended to provide an overview of the evidence and support endoscopists and patients on the use of computer-aided detection (CADe) systems for the detection of colorectal polyps during colonoscopy.
A multidisciplinary panel of content experts and guideline methodologists used the Grading of Recommendations Assessment, Development and Evaluation framework and relied on the following sources of evidence: (1) a systematic review examining the desirable and undesirable effects (ie, benefits and harms) of CADe-assisted colonoscopy, (2) a microsimulation study estimating the effects of CADe on longer-term patient-important outcomes, (3) a systematic search of evidence evaluating the values and preferences of patients undergoing colonoscopy, and (4) a systematic review of studies evaluating health care providers' trust in artificial intelligence technology in gastroenterology.
The panel reached the conclusion that no recommendation could be made for or against the use of CADe-assisted colonoscopy in light of very low certainty of evidence for the critical outcomes, desirable and undesirable (11 fewer colorectal cancers per 10,000 individuals and 2 fewer colorectal cancer deaths per 10,000 individuals), increased burden of more intensive surveillance colonoscopies (635 more per 10,000 individuals), and cost and resource implications. The panel acknowledged the 8% (95% CI, 6%-10%) increase in adenoma detection rate and 2% (95% CI, 0%-4%) increase in advanced adenoma and/or sessile serrated lesion detection rate.
This guideline highlights the close tradeoff between desirable and undesirable effects and the limitations in the current evidence to support a recommendation. The panel acknowledged the potential for CADe to continually improve as an iterative artificial intelligence application. Ongoing publications providing evidence for critical outcomes will help inform a future recommendation.
本美国胃肠病学会(AGA)指南旨在概述相关证据,并为内镜医师和患者在结肠镜检查中使用计算机辅助检测(CADe)系统检测结直肠息肉提供支持。
一个由内容专家和指南方法学家组成的多学科小组采用推荐分级评估、制定和评价框架,并依据以下证据来源:(1)一项系统评价,考察CADe辅助结肠镜检查的有益和不良影响(即益处和危害);(2)一项微观模拟研究,估计CADe对长期患者重要结局的影响;(3)对评估接受结肠镜检查患者的价值观和偏好的证据进行系统检索;(4)对评估医疗保健提供者对胃肠病学人工智能技术信任度的研究进行系统评价。
鉴于关键结局(有益和不良)的证据确定性非常低(每10,000人中结直肠癌减少11例,每10,000人中结直肠癌死亡减少2例)、强化监测结肠镜检查负担增加(每10,000人中增加635例)以及成本和资源影响,该小组得出结论,无法就是否使用CADe辅助结肠镜检查给出推荐意见。该小组承认腺瘤检出率提高了8%(95%CI,6%-10%),高级腺瘤和/或无蒂锯齿状病变检出率提高了2%(95%CI,0%-4%)。
本指南强调了有益和不良影响之间的密切权衡以及当前证据支持推荐意见的局限性。该小组承认CADe作为一种迭代人工智能应用有持续改进的潜力。正在发表的提供关键结局证据的文献将有助于为未来的推荐意见提供参考。